Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 24, 2008
RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reductionJ R Curtis, A O Westfall, H Cheng, et al.
The Journal of Infectious Diseases|March 1, 1993
Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistenceF Foto, K G Saag, L L Scharosch, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 15, 2016
The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USAN C Wright, K G Saag, B Dawson-Hughes, et al.
Arthritis and Rheumatism|November 1, 1996
Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectivenessK G Saag, L A Criswell, K M Sems, et al.
Rheumatology (Oxford, England)|May 5, 2005
Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)T R Mikuls, J T Farrar, W B Bilker, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2006
Channeling and adherence with alendronate and risedronate among chronic glucocorticoid usersJ R Curtis, A O Westfall, J J Allison, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 23, 2017
The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentationN C Wright, K G Saag, B Dawson-Hughes, et al.
Acta Reumatologica Portuguesa|April 7, 2015
Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritisT Santiago, J W Jacobs, K G Saag, et al.
Annals of the Rheumatic Diseases|August 1, 1997
Cigarette smoking and rheumatoid arthritis severityK G Saag, J R Cerhan, S Kolluri, et al.
Scandinavian Journal of Rheumatology|May 21, 2005
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritisF Buttgereit, K G Saag, M Cutolo, et al.
Pageof 9